Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

News snapshot: Gold Resource Corporation, The Valens Company, Endexx, Cardiol Therapeutics, Westwater Resources, Singlepoint UPDATE...

Regency Silver Corp. (TSX-V:RSMX, OTCQB:RSMXF) said an updated resource estimate for its Dios Padre gold-copper-silver project in Sonora, Mexico, incorporating new drilling data has increased the estimated size of the resource.

In a statement, the company said that the updated inferred resource for Dios Padre has been estimated at 11.375 million ounces of silver equivalent, represented by 1.384 million tonnes at 255.64 grams per tonne of silver equivalent.

Read more

Québec Nickel Corp (CSE:QNI, OTCQB:QNICF) has announced that its winter 2023 drilling program will begin within the next 10 days at the Ducros nickel-copper-platinum group elements (Ni-Cu-PGE) project in Québec, following the completion of a financing that raised over $8.5 million.

The mineral exploration company said a total of 20,000 metres is expected to be completed at the Fortin Sill Zone, Ducros Ultramafic Sill Complex and Ducros Gabbro targets.

Read more

Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) has said is planning a new capital raise to finance its exploration activities in the southwestern US.

The company revealed a non-brokered private placement of up to 6 million units at a price of $0.15 per unit, for total proceeds of up to $900,000.

Read more

BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) said it has appointed Dr George Garibaldi, who has more than 40 years of experience in drug development and the pharmaceutical industry, to its Scientific Board of Advisors.

Dr Garibaldi is the co-founder and president of research and development of Noema Pharma AG and he has previously held leadership responsibilities at several major pharmaceutical companies, more recently serving as VP and Global Head of Clinical Neuroscience at F Hoffmann-La Roche, BioHarvest said.

Read more

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that its subsidiary, Algernon NeuroScience (AGN Neuro), has dosed the first subject in its Phase 1 clinical study of an intravenous formulation of AP-188 (N,N-Dimethyltryptamine or DMT) at the Centre for Human Drug Research in Leiden, Netherlands.

The company said DMT is a known psychedelic compound that is part of the tryptamine family and is an agonist of multiple receptors, including serotonin receptors and the sigma-1 receptor. Sigma-1 is a multi-faceted stress-responsive receptor that promotes cell survival, neuroprotection, neuroplasticity, and neuroimmunomodulation, it added.

Read more

Nextech AR Solutions Corp. (CSE:NTAR, OTCQX:NEXCF) has announced an expansion contract with thousands of 3D model products for Majid Al Futtaim, a branding partner for fashion and retail brands with over 100 stores across the Middle East and North Africa (MENA) region, including brands such as Crate & Barrel, Hollister, AllSaints, and lululemon Athletica.

The company also said that it now supplies 3D models for Procter & Gamble (NYSE:PG), an S&P 500 company, as well as Bunning, which has 381 locations and is the largest retailer of home improvement supplies in Australia and New Zealand.

Read more

Lucky Minerals (TSX-V:LKY, OTC:LKMNF) has confirmed that the maximum amount payable in shares for services under the non-arm's-length letter of intent and drilling contract with Hubbard Perforaciones Ecuador Cia Ltda (a private company owned by Lance Hubbard, a non-arm's-length party), dated December 8, 2021, as amended, shall be 20 million common shares over the time of the agreement (if the company elects to pay in shares). The contract is subject to the approval of the TSX Venture Exchange (TSX-V). All shares issued are subject to a hold period of four months plus a day from the date of issuance of the shares in accordance with applicable securities legislation and the policies of the TSX-V.

Hillcrest Energy Technologies Ltd (CSE:HEAT, OTCQB:HLRTF) will hold an investor webinar on February 14, 2023 at 4:05pm ET. Hosted by Amvest Capital, the webinar will provide an operational overview that includes updates on the company's technology and product development efforts, commercialization activities as well as insights into the company's strategic investor and public relations efforts. In addition to Hillcrest CEO, Don Currie, participants for this webinar will include Chief Technology Officer Ari Berger, Chief Commercialization Officer, James Bolen and Harald Hengstenberger, Managing Director, Owner & Founder of Systematec GmbH. Investors can register with Amvest Capital for the webinar at: https://www.amvestcapital.com/webinar-directory/hillcrestenergy021423.

Nextech AR Solutions Corp. (CSE:NTAR, OTCQX:NEXCF) CEO Evan Gappelberg will be attending the virtual Investor Summit on January 26th, 2023 at 12:30 p.m. EST. Interested participants may register here: https://us06web.zoom.us/webinar/register/WN_0JLg-aH8QQuGqwU2B7muMw.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK